doi: 10.1176/ajp.150.4.656.
Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression
Affiliations
- PMID: 8465888
- DOI: 10.1176/ajp.150.4.656
Item in Clipboard
Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression
Am J Psychiatry.
1993 Apr.
Abstract
The authors measured CSF concentrations of corticotropin-releasing hormone (CRH) and arginine vasopressin in nine depressed patients before and after fluoxetine treatment. They found significant decreases in CSF CRH, CSF arginine vasopressin, and Hamilton depression ratings. Thus, the therapeutic effect of this serotonin-uptake inhibitor may be related to diminution of these arousal-promoting neuropeptides.
Similar articles
-
Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.Biol Psychiatry. 1995 Sep 1;38(5):330-5. doi: 10.1016/0006-3223(95)00229-A. Biol Psychiatry. 1995. PMID: 7495928 No abstract available.
-
Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.Psychopharmacology (Berl). 2016 Mar;233(6):1077-86. doi: 10.1007/s00213-015-4187-4. Epub 2015 Dec 23. Psychopharmacology (Berl). 2016. PMID: 26700241
-
Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.Depress Anxiety. 1998;8(2):71-9. Depress Anxiety. 1998. PMID: 9784981
-
Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus.Vitam Horm. 2010;82:339-65. doi: 10.1016/S0083-6729(10)82018-7. Vitam Horm. 2010. PMID: 20472147 Review.
-
Role of corticotrophin releasing hormone 41 in depressive illness.Baillieres Clin Endocrinol Metab. 1991 Mar;5(1):51-8. doi: 10.1016/s0950-351x(05)80096-5. Baillieres Clin Endocrinol Metab. 1991. PMID: 2039428 Review.
Cited by
-
Mechanisms of Psychiatric Comorbidities in Epilepsy.Curr Top Behav Neurosci. 2022;55:107-144. doi: 10.1007/7854_2020_192. Curr Top Behav Neurosci. 2022. PMID: 33723802
-
[Latest Findings on the Interaction Mechanism Between Depressive Disorder and Intestinal Permeability].Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Mar;54(2):257-262. doi: 10.12182/20230360503. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 36949682 Free PMC article. Review. Chinese.
-
Behavioural and physiological responses of birds to environmentally relevant concentrations of an antidepressant.Philos Trans R Soc Lond B Biol Sci. 2014 Nov 19;369(1656):20130575. doi: 10.1098/rstb.2013.0575. Philos Trans R Soc Lond B Biol Sci. 2014. PMID: 25405964 Free PMC article.
-
Innovative approaches for the treatment of depression: targeting the HPA axis.Neurochem Res. 2008 Apr;33(4):691-707. doi: 10.1007/s11064-007-9518-3. Epub 2007 Oct 25. Neurochem Res. 2008. PMID: 17960478 Review.
-
Interaction of stress, corticotropin-releasing factor, arginine vasopressin and behaviour.Curr Top Behav Neurosci. 2014;18:67-80. doi: 10.1007/7854_2014_306. Curr Top Behav Neurosci. 2014. PMID: 24659554 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
